Abstract
Favorable Outcomes in Elderly and High-Risk Patients with AML and MDS Following T-Cell Depleted Reduced Intensity Conditioned Allogeneic Stem Cell Transplantation
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have